Skip to main content

Financial Perspectives, Inc

Position in NVO — Novo Nordisk A S

CIK 2003287 MINNEAPOLIS, MN

Position in NVO

as of Jun 30, 2026 · filed Jul 24, 2026
Position Value
$539,612
+$125,954 QoQ
Shares Held
11,256
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#686
of 1,347 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Financial Perspectives, Inc holds $10,204,212 across 14 Drug Manufacturers - General names. NVO ranks #6 (5.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 NVO
Novo Nordisk A S
This page
11,256 $539,612

All Filings in NVO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $539,612 11,256
2026-03-31 $413,658 11,256
2025-12-31 $572,705 11,256
2025-09-30 $631,420 11,379
2025-06-30 $776,889 11,256
2025-03-31 $781,616 11,256
2024-12-31 $968,241 11,256
2024-09-30 $1,332,988 11,195
2024-06-30 $1,621,526 11,360
2024-03-31 $1,458,624 11,360
2023-12-31 $1,173,640 11,345
2023-09-30 $1,028,622 11,311
2023-06-30 $915,148 5,655
2023-03-31 $899,936 5,655
2022-12-31 $765,347 5,655
2022-09-30 $559,721 5,618
2022-06-30 $626,013 5,618
2022-03-31 $623,878 5,618
2021-12-31 $603,456 5,388
2021-09-30 $378,183 3,939
2021-06-30 $707,437 8,445
2021-03-31 $8,445 569,379
2020-12-31 $589,883 8,445
2020-09-30 $589,807 8,495
2020-06-30 $556,187 8,494
2020-03-31 $511,218 8,492